Literature DB >> 14762665

Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vacuum technique.

Meinhard Nevinny-Stickel1, Reinhart A Sweeney, Reto J Bale, Andrea Posch, Thomas Auberger, Peter Lukas.   

Abstract

BACKGROUND AND
PURPOSE: Precise reproducible patient positioning is a prerequisite for conformal fractionated radiotherapy. A fixation system based on double-vacuum technology is presented which can be used for conventional as well as hypofractionated stereotactic extracranial radiotherapy.
MATERIAL AND METHODS: To form the actual vacuum mattress, the patient is pressed into the mattress with a vacuum foil which can also be used for daily repositioning and fixation. A stereotactic frame can be positioned over the region of interest on an indexed base plate. Repositioning accuracy was determined by comparing daily, pretreatment, orthogonal portal images to the respective digitally reconstructed radiographs (DRRs) in ten patients with abdominal and pelvic lesions receiving extracranial fractionated (stereotactic) radiotherapy. The three-dimensional (3-D) vectors and 95% confidence intervals (CI) were calculated from the respective deviations in the three axes. Time required for initial mold production and daily repositioning was also determined.
RESULTS: The mean 3-D repositioning error (187 fractions) was 2.5 +/- 1.1 mm. The largest single deviation (10 mm) was observed in a patient treated in prone position. Mold production took an average of 15 min (10-30 min). Repositioning times are not necessarily longer than using no positioning aid at all.
CONCLUSION: The presented fixation system allows reliable, flexible and efficient patient positioning for extracranial stereotactic radiotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 14762665     DOI: 10.1007/s00066-004-1146-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Development of a navigation system for minimally invasive esophagectomy.

Authors:  H G Kenngott; J Neuhaus; B P Müller-Stich; I Wolf; M Vetter; H-P Meinzer; J Köninger; M W Büchler; C N Gutt
Journal:  Surg Endosc       Date:  2007-12-20       Impact factor: 4.584

2.  A Robust and Affordable Table Indexing Approach for Multi-isocenter Dosimetrically Matched Fields.

Authors:  Amy Yu; Benjamin Fahimian; Lynn Million; Annie Hsu
Journal:  Cureus       Date:  2017-05-23

3.  Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II study.

Authors:  Alfred Haidenberger; Sabine Fromm-Haidenberger; Alexander de Vries; Bela-Andre Popper; Michael Steurer; Ira Skvortsova; Johanna Kantner; Eberhard Gunsilius; Peter Lukas
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

4.  Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study.

Authors:  Antje Ernst-Stecken; Ulrike Lambrecht; Reinhold Mueller; Rolf Sauer; Gerhard Grabenbauer
Journal:  Strahlenther Onkol       Date:  2006-12       Impact factor: 3.621

5.  Proton radiotherapy for solid tumors of childhood.

Authors:  Shane E Cotter; Sean M McBride; Torunn I Yock
Journal:  Technol Cancer Res Treat       Date:  2012-03-15

6.  Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results.

Authors:  Fumiya Baba; Yuta Shibamoto; Natsuo Tomita; Chisa Ikeya-Hashizume; Kyota Oda; Shiho Ayakawa; Hiroyuki Ogino; Chikao Sugie
Journal:  Radiat Oncol       Date:  2009-05-28       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.